ACATECHOL, INC.
Central venous catheters with covalently immobilized antimicrobial gemini dicationic and biofilm-repellent zwitterionic surface coatings
- Sector
- Medtech
- Headquarters
- SANTA BARBARA, CA
- Founded
- 2016
- Latest Form D
- $400K, Feb 2016
- Total capital
- $1.5M
- Federal grants
- $1.1M
- 5 awards · 2020–2025
- Rank in peer group#6 of 477
- Private capital raised
- $400K
- 1 Form D · last Feb 2016
- 129 months since last filing
- Federal contracts
- None on recordNo federal contract awards found.
- Granted patents
- 4
- 23 pending · first 2019
- Rank in peer group#79 of 477
Capital timeline
Latest events
- Federal grantDefense · Phase I · Dha SBIR Ph I Topic DHA242-003, Proposal H242-003-0066 Titled "bioinspired Chitosan-based Hydrogels For Neuroprotective Treatment For Traumatic Brain Injury", Medical R And D$250K
- Federal grantHealth and Human S · Phase I · Hybrid repellant-antimicrobial gemini coatings for prevention of catheter-associated bloodstream infections$55K
- Federal grantNSF · Phase I · SBIR Phase I: Anti-infective Foley catheters for long-term prevention of catheter-associated urinary tract infections$275K
- Federal grantHealth and Human S · Phase I · Hybrid repellant-antimicrobial gemini coatings for prevention of catheter-associated bloodstream infections$273K
- Federal grantNSF · Phase I · SBIR Phase I: Virucidal surface coatings for prevention of COVID-19 transmission$276K
- Private capital raisedForm D · SEC · 1st filing$400K
Node area is scaled to amount. Form D reports securities sold, which can differ from an announced round; filings are numbered in the order they were made.
Standing among 477 peers
Line = medianMedtech · Device
- Federal grants#6 · top 1%
- Granted patents#79 · top 17%
Cumulative measures favor older companies. Rankings describe position today, not outcome. Below the median, ranks show as a band rather than a number.
Founders and team
From SEC Form D filings- Byung-Jun AhnExecutive Officer, DirectorNamed in SEC Form D filings
- Eric Cook RyanDirectorNamed in SEC Form D filings
- Jin-Soo AhnExecutive Officer, DirectorNamed in SEC Form D filings
What it has protected
USPTO · 4 granted of 27- PendingIndwelling Medical DeviceUSPTOApplication 19540347
- PendingCompositions And Methods For Tissue RepairUSPTOApplication 18712368
- GrantedIonic Polymers And Their Use As Wet-adhesives And CoatingsUSPTOUS 11,214,715
Show all 27 patent records
- Indwelling Medical DeviceJun 25, 2026 · Application 19540347Pending
- Compositions And Methods For Tissue RepairJan 16, 2025 · Application 18712368Pending
- Ionic Polymers And Their Use As Wet-adhesives And CoatingsJan 4, 2022 · US 11,214,715Granted
- Molecularly Well-defined Antibiofouling and Polyionic CoatingsJan 21, 2021 · Application 16932332Pending
- Surface Primer Compositions And Methods Of UseJun 30, 2020 · US 10,696,698Granted
- Photo-cleavable Primer Compositions And Methods Of UseJun 23, 2020 · US 10,689,407Granted
- Ionic Polymers And Their Use As Wet-adhesives And CoatingsOct 8, 2019 · US 10,435,599Granted
- Formulations And Applications Of Wet-adhesivesJun 21, 2018 · Application 15845738Pending
- Formulations And Applications Of Wet-adhesivesApplication PCTUS2017067052Pending
- Ionic Polymers And Their Use As Wet-adhesives And CoatingsApplication PCTUS2017037196Pending
- Photo-cleavable Primer Compositions And Methods Of UseApplication PCTUS2017015298Pending
- Surface Primer Compositions And Methods Of UseApplication PCTUS2017015262Pending
- Formulations And Applications Of Wet-adhesivesApplication 62436285Pending
- Ionic Polymers And Their Use As Wet-adhesivesApplication 62363605Pending
- Surface Primer Compositions and Methods of UseApplication 62360677Pending
- Ionic Polymers And Their Use As Wet-adhesivesApplication 62349328Pending
- Surface Primer Compositions and Methods of UseApplication 62309156Pending
- Photo-Cleavable Primer Compositions and Methods of UseApplication 62309162Pending
- Surface Primer Compositions and Methods of UseApplication 62288195Pending
- Photo-Cleavable Primer Compositions and Methods of UseApplication 62288281Pending
- Medical Device With Interpenetrated Polymer Network And Related MethodsApplication PCTUS2024042818Pending
- Hydrophobic-hydrophilic Interpenetrated Network and Its Composition and Methods of UseApplication 63533236Pending
- Antifouling Materials, Compositions And Methods Of UseApplication PCTUS2022033297Pending
- Compositions And Methods For Tissue RepairApplication 63287365Pending
- Antifouling Materials, Compositions and Methods of UseApplication 63209884Pending
- Molecularly Well-defined Antibiofouling And Polyionic CoatingsApplication PCTUS2020042581Pending
- Molecularly Well-defined Antibiofouling and Polyionic CoatingsApplication 62876404Pending
Related companies, and why
- Apollo Neuroscience, Inc.Similar federal contract value in Medtech · null in contracts
- EPIRUS, INC.Similar federal contract value in Medtech · null in contracts
- PeriCor LLCSimilar federal contract value in Medtech · null in contracts
- SEETRUE TECHNOLOGY, LLCSimilar federal contract value in Medtech · null in contracts
- HEROWEAR, LLCSimilar federal contract value in Medtech · null in contracts
- Cagent Vascular, Inc.Similar federal contract value in Medtech · null in contracts
Regulatory activity · Medtech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.
Sources
Federal grants from SBIR/STTR, NIH, NSF and DoD records. Federal contracts from USAspending.gov. Private capital from SEC Form D. Patents from USPTO. Publications from OpenAlex. Regulatory activity from the Federal Register. Press matched on company name.
How to read this page
Figures show associations in public records, not causes or predictions. Nothing here is investment advice. An em-dash means no record was found under this company's name, not that none exists.
Data freshness
SEC Form D filings through . SBIR and STTR awards through .